Clinical Efficacy of Entecavir Combined with Lactulose in the Treatment of Post-hepatitis B Cirrhosis and Its Effects on Serum HBV-DNA, KLF2 and TNFSF15

WANG Hong-gui; TANG Shi-wei; ZHENG Yong-chi

doi:10.3969/j.issn.1002-3429.2020.06.009

Home>Articles>Clinical Efficacy of Entecavir Combined with Lactulose in the Treatment of Post-hepatitis B Cirrhosis and Its Effects on Serum HBV-DNA, KLF2 and TNFSF15

DOI: 10.3969/j.issn.1002-3429.2020.06.009

Clinical Efficacy of Entecavir Combined with Lactulose in the Treatment of Post-hepatitis B Cirrhosis and Its Effects on Serum HBV-DNA, KLF2 and TNFSF15

WANG Hong-gui

TANG Shi-wei

ZHENG Yong-chi

Machine-generated Keywords：

Publication Date：2020-06-22

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 33-37 )

Clinical Misdiagnosis & Mistherapy

ISTIC

ISSN：1002-3429

Year, Vol.(Issue)：2020,33(6)